A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.

Nano-sizing offers a promising method for the formulation of poorly aqueous soluble compounds. Nanosuspensions can be prepared by top-down or bottom-up approaches. The different conditions encountered in these two approaches can greatly affect nanosuspension characteristics. In this study, milling via microfluidization and precipitation via sonication were compared to study their effects on the formation and stability of ibuprofen nanosuspensions. Various stabilizers (SLS, PVP K-30, Pluronic F-68 and F-127, Tween 80 and different hydroxypropyl methylcelluloses (HPMCs)) were evaluated. Both processes resulted in a similar trend in the initial particle size and comparable short-term physical stability of suspensions. Of all the stabilizers investigated, the HPMCs were the most effective both in terms of particle size reduction and short-term physical stability. Differences in stabilizer efficacy were observed between the two processing methods. The initial particle size of the suspensions prepared using microfluidization correlated with the solubility of ibuprofen in the respective stabilizer solutions. Whereas, the initial particle size of suspensions prepared using precipitation under sonication correlated with the HLB values of the stabilizers. The solubility of ibuprofen in the stabilizer solution also played a significant role in the increase in particle size on storage, indicating Ostwald ripening.

[1]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[2]  M. Ticehurst,et al.  Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide. , 2000, International journal of pharmaceutics.

[3]  R. O. Williams,et al.  Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered-dose inhaler formulation. , 1999, Pharmaceutical development and technology.

[4]  J-Y Choi,et al.  Characteristics of polymers enabling nano-comminution of water-insoluble drugs. , 2008, International journal of pharmaceutics.

[5]  John A. Lowe,et al.  A guide to drug discovery: The role of the medicinal chemist in drug discovery — then and now , 2004, Nature Reviews Drug Discovery.

[6]  S. Dwivedi,et al.  Increase in the Specific Surface Area of Budesonide During Storage Postmicronization , 2004, Pharmaceutical Research.

[7]  G. Buckton,et al.  The use of surface energy and polarity determinations to predict physical stability of non-polar, non-aqueous suspensions , 1992 .

[8]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.

[9]  P Amsa,et al.  Nanosuspensions: A Promising Drug Delivery Strategy , 2010 .

[10]  Jerry Y. Y. Heng,et al.  The Effects of Milling on the Surface Properties of Form I Paracetamol Crystals , 2006, Pharmaceutical Research.

[11]  Pieter Walstra,et al.  Formation of emulsions. , 1998 .

[12]  Maurice Dickins,et al.  Compound lipophilicity for substrate binding to human P450s in drug metabolism. , 2004, Drug discovery today.

[13]  Vandana B. Patravale,et al.  Current strategies for engineering drug nanoparticles , 2004 .

[14]  P. Byron,et al.  Surfactant promoted crystal growth of micronized methylprednisolone in trichloromonofluoromethane , 1994 .

[15]  J. Swanson,et al.  Use of microfluidizer processing for preparation of pharmaceutical suspensions , 1996 .

[16]  Jonghwi Lee,et al.  Role of polymeric stabilizers for drug nanocrystal dispersions , 2005 .

[17]  C. Lipinski Poor aqueous solubility-an industry wide problem in drug discovery , 2002 .

[18]  Sandip S Chavhan,et al.  Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects. , 2011, Critical reviews in therapeutic drug carrier systems.

[19]  M. Descamps,et al.  Evidence for a New Crystalline Phase of Racemic Ibuprofen , 2008, Pharmaceutical Research.

[20]  R. Hüttenrauch,et al.  Mechanical Activation of Pharmaceutical Systems , 1985, Pharmaceutical Research.